An alpha2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man
Authors:
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 97 (1) , 115-117
Abstract
Nocturnal plasma melatonin concentration was significantly increased in ten normal volunteers following the administration of an alpha2 adrenoceptor antagonist, Org 3770 (30 mg). This result supports the existence of an alpha2 adrenergic influence on melatonin secretion in man and provides a possible clinical neuroendocrine marker of the action of an alpha2 antagonist.Keywords
This publication has 21 references indexed in Scilit:
- Evidence for a functional role of alpha-1 adrenoceptors in the regulation of melatonin secretion in manPsychoneuroendocrinology, 1989
- The effect of clonidine and bright light on plasma melatoninHuman Psychopharmacology: Clinical and Experimental, 1988
- Classification of GABA and benzodiazepine receptorsJournal of Psychopharmacology, 1987
- Circadian rhythms in mammalian neurotransmitter receptorsProgress in Neurobiology, 1987
- Effects of a phosphodiesterase inhibitor (Rolipram) on the urinary excretion of 6-sulphatoxy melatonin in manJournal of Psychopharmacology, 1987
- Clonidine reduces plasma melatonin levelsJournal of Pharmacy and Pharmacology, 1986
- Hamster and Rat Pineal Gland ?-Adrenoceptor Characterization With Iodocyanopindolol and the Effect of Decreased Catecholamine Synthesis on the ReceptorJournal of Pineal Research, 1985
- Pineal N-acetyltransferase and hydroxyindole-O-methyl-transferase: control by the retinohypothalamic tract and the suprachiasmatic nucleusBrain Research, 1979
- Loss of circadian rhythm in sleep-wakefulness cycle in the rat by suprachiasmatic nucleus lesionsBrain Research, 1975
- Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the ratBrain Research, 1972